Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-18

FDA Approved: EYE ALLERGY RELIEF — Supplemental Application (DOLGENCORP, LLC)

View source ↗

Summary

FDA approved a supplemental application for Eye Allergy Relief containing pheniramine maleate and naphazoline hydrochloride, filed by DolgenCorp, LLC, indicatin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naphazoline Hydrochloride (NAPHAZOLINE HYDROCHLORIDE)
  • Pheniramine Maleate (PHENIRAMINE MALEATE)

Snippet

SUPPL AP for EYE ALLERGY RELIEF (PHENIRAMINE MALEATE AND NAPHAZOLINE HYDROCHLORIDE)